If you had acne in the 90’s, you may be familiar with a drug called Accutane. While the drug had a warning label that noted it is “associated with” chronic bowel problems, the Plaintiff’s argued that Roche (the company which manufactures Accutane) did not accurately warn users of the risk of Chronic Bowel Disorder. Roch was ordered to pay $13 million to the three Plaintiffs.
Three patients claimed they developed a chronic bowel disorder as a result of using this drug: one will have to have his colon surgically removed and the other two will require long-term drug therapy.
This entry was posted on Friday, November 21st, 2008 at 1:35 pm and is filed under Defective Products, Disease Claims, Medical Information, Negligence Cases. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
Leave a Reply
|
Douglas K.W. Landau is admitted to practice in DC, VA, CT, FL, and NJ. Abrams Landau services clients in Washington DC, Pennsylvania, PA, Maryland, MD, Virginia, VA (including Northern Virginia, Fairfax county, Loudoun county, Herndon, Reston, and more), Connecticut, CT, Georgia, GA, Florida, FL, New Hampshire, NH, New York, NY, New Jersey, NJ, Maine, Massachusetts, MA, Rhode Island, RI, North Carolina, NC, and South Carolina, SC.
Information disseminated on this website is intended for informational purposes only and is not legal advice. This information is not intended to create an attorney-client or similar relationship. Please do not send us confidential information. Past successes cannot be an assurance of future success. Whether you need legal services and which lawyer you select are important decisions that should not be based solely upon this website. Please contact: Abrams Landau Ltd. at (703) 796-9555.
Entries (RSS)